Michael Weiss, MD
Otolaryngology · Brooklyn, NYNPI 1417937335
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Olympus America Inc. at 56.9% of the total. 2025 is the largest year on record at $869, 2.6 times the $338 reported in 2019.
Across 24 payments — averaging $62.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$853
- Optinose US, Inc.$199
- Stryker$128
- Axogen$68
- 3nt Medical$61
- Acclarent, Inc$37
- plus $152 from 7 others
What the payments were for
- Food & beverage$64543%
- Other$85357%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 1 | $853 |
| Optinose US, Inc. | 10 | $199 |
| Stryker | 2 | $128 |
| Axogen | 1 | $68 |
| 3nt Medical | 1 | $61 |
| Acclarent, Inc | 2 | $37 |
| Medtronic | 1 | $36 |
| Intersect ENT, Inc. | 1 | $30 |
| Sanofi | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $17 |
| Kls-martin L.p. | 1 | $15 |
| Providence Medical Technology, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Gyrus ACMI$853
How this compares
$1,498 in reported general payments places this provider in the 55th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 139 | $1,340 |
| Ipratropium Bromide | 45 | $1,046 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 22 | $956 |
| Mometasone Furoate | 14 | $652 |
| Cefdinir | 27 | $527 |
| Ofloxacin | 11 | $412 |
| Levothyroxine Sodium | 16 | $161 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $146 |
| Montelukast Sodium | 23 | $103 |
| Omeprazole | 22 | $97 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Brooklyn
- Michael SingerBrooklyn$39K
- Boris BentsianovBrooklyn$19K
- Sydney ButtsBrooklyn$12K
- Robert KellmanSyracuse$2.5M
- Roheen RaithathaNew York$830K
- Nora PerkinsAlbany$300K
- Moshe EphratNew Hyde Park$250K
- Gavin SetzenAlbany$243K
- Habibullah JamalRye Brook$179K
- Albert JenFlushing$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.